Top Page
Paramount Bed Holdings Co
(7817)
Paramount Bed Holdings Co (7817) vs. iShares MSCI Japan ETF (EWJ)
Paramount Bed Holdings Co Business Overview & Revenue Model
Paramount Bed Holdings Co Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 108.03B | 108.58B | 106.02B | 99.01B | 90.35B | 87.17B |
| Gross Profit | 51.80B | 52.56B | 50.63B | 47.20B | 43.03B | 40.44B |
| EBITDA | 19.19B | 24.14B | 25.38B | 22.45B | 21.50B | 20.55B |
| Net Income | 9.92B | 9.08B | 10.62B | 9.21B | 9.09B | 8.61B |
Balance Sheet | ||||||
| Total Assets | 178.11B | 183.03B | 180.02B | 172.29B | 164.28B | 154.36B |
| Cash, Cash Equivalents and Short-Term Investments | 41.54B | 43.54B | 46.75B | 53.23B | 54.07B | 48.36B |
| Total Debt | 6.87B | 6.80B | 5.96B | 5.51B | 6.13B | 7.13B |
| Total Liabilities | 42.58B | 45.74B | 44.01B | 43.60B | 42.61B | 40.54B |
| Stockholders Equity | 135.53B | 137.28B | 136.01B | 128.69B | 121.67B | 113.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.09B | 3.29B | 5.35B | 6.30B | 6.56B |
| Operating Cash Flow | 0.00 | 10.45B | 7.52B | 9.15B | 7.82B | 10.28B |
| Investing Cash Flow | 0.00 | 264.00M | -8.16B | -6.33B | -220.00M | -1.54B |
| Financing Cash Flow | 0.00 | -8.80B | -5.97B | -3.23B | -3.37B | -3.04B |
Paramount Bed Holdings Co Technical Analysis
Paramount Bed Holdings Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $192.21B | 23.53 | 6.38% | 3.11% | 2.72% | -6.31% | |
| ― | ¥197.65B | 15.52 | 10.03% | 2.53% | 7.28% | 1.72% | |
| ― | €179.19B | 34.68 | 4.39% | 2.53% | 10.98% | -76.45% | |
| ― | ¥244.24B | 43.51 | 2.49% | 2.00% | 8.83% | -40.24% | |
| ― | $117.07B | 95.31 | 0.78% | 1.61% | -2.06% | -79.17% | |
| ― | ¥10.53B | ― | ― | 3.89% | 3.36% | -310.49% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Paramount Bed Holdings Co Corporate Events
Paramount Bed Holdings Co., Ltd. has announced its support for a management buyout (MBO) led by TMKR Co., Ltd., recommending shareholders to tender their shares. This strategic move aims to privatize the company by delisting its shares from the Tokyo Stock Exchange, potentially impacting its operational control and market presence.
The most recent analyst rating on (JP:7817) stock is a Buy with a Yen2950.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.
Paramount Bed Holdings Co., Ltd. announced a partial amendment to its previous notice regarding the disposal of treasury shares as a restricted stock incentive for its Employee Shareholding Association. This amendment, resolved at a recent Board of Directors meeting, includes provisions for lifting transfer restrictions in the event of a tender offer for the company’s common shares, which could impact the company’s stock management and employee incentives.
The most recent analyst rating on (JP:7817) stock is a Buy with a Yen2950.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.
Paramount Bed Holdings Co., Ltd. announced an amendment to its previous notice regarding the disposal of treasury shares as a restricted stock incentive for its Employee Shareholding Association. This amendment introduces conditions under which transfer restrictions on shares can be lifted, particularly in the event of a tender offer supported by the company’s board. This move is likely to impact the company’s stock management strategy and could influence shareholder decisions, reflecting a strategic approach to employee incentives and stockholder engagement.
The most recent analyst rating on (JP:7817) stock is a Buy with a Yen2950.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.
Paramount Bed Holdings Co., Ltd. announced a revision of its dividend forecast for the fiscal year ending March 2026, deciding not to pay any interim or year-end dividends. This decision is linked to a tender offer by TMKR Co., Ltd., which is expected to result in the delisting of the company’s shares. Additionally, the company will abolish its shareholder benefit plan, contingent on the successful completion of the tender offer. These strategic changes aim to reinforce the company’s financial health and adapt to anticipated rapid changes in the business environment.
The most recent analyst rating on (JP:7817) stock is a Buy with a Yen2950.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.
Paramount Bed Holdings Co., Ltd. has revised its earnings forecasts for the first six months of the fiscal year ending March 2026, citing reduced net sales due to a cautious investment approach by Japanese medical institutions and delays in overseas deals. Despite these challenges, the company maintains its full-year forecast, driven by positive developments in its nursing care business and profit improvement measures.
The most recent analyst rating on (JP:7817) stock is a Buy with a Yen2950.00 price target. To see the full list of analyst forecasts on Paramount Bed Holdings Co stock, see the JP:7817 Stock Forecast page.
Paramount Bed Holdings Co., Ltd. reported a decline in its financial performance for the first quarter of the fiscal year ending March 31, 2026, with net sales decreasing by 3.8% and operating profit dropping by 31.8% compared to the previous year. Despite the downturn, the company maintains a strong equity-to-asset ratio of 76.6%, and it has not revised its earnings forecasts, projecting a moderate growth in net sales and profit for the full fiscal year.